|
|
|
Drug Developers’ Stock Decline
Apr 16, 4:54 PM EDT |
|
| Sixty two companies priced shares so far in 2006, and 65% of them are trading above their offering price. |
|
| Two drug discovery companies'' initial public offerings fell in their first day of trading, as investors avoided higher-risk deals. Biopharmaceutical companies Targacept and Vanda Pharmaceuticals both priced $2 below their expected ranges, and then went lower. |
|
|
Full Story... |
1
 |
|
